Zelgen(SH:688266) Xin Lang Cai Jing·2025-10-30 02:31Core Viewpoint - Zai Jian Pharmaceutical's stock increased by 5.09% to 91.43 CNY per share, with a market capitalization of 24.202 billion CNY as of October 30 [1] Company Overview - Suzhou Zai Jian Biopharmaceutical Co., Ltd. was established on March 18, 2009, and went public on January 23, 2020 [1] - The company's main business involves the research, production, and sales of chemical new drugs and biological new drugs, with 99.97% of revenue coming from pharmaceuticals [1] Fund Holdings - One fund under Industrial Bank, the Industrial Medical Care A (011466), holds 143,000 shares of Zai Jian Pharmaceutical, unchanged from the previous period, representing 4% of the fund's net value [2] - The fund has a total size of 261 million CNY and has achieved a year-to-date return of 24.05% [2] - The fund manager, Chen Xu, has been in position for 4 years and 238 days, with the best and worst fund returns during his tenure being -19.16% and -21.01%, respectively [2]